Key Drivers
- Cash Conversion
- Margin Pressure
- Tight Liquidity
AIAI Summary
ICLR is now a governance-and-credibility story before it is a CRO growth story: until the audit review, any restatement risk, and delayed filings are resolved, the stock is likely capped by trust concerns and compressed margins despite solid cash generation and strategic growth options.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Conversion
- •Margin Pressure
- •Tight Liquidity
ICLR remains cash-generative with a solid balance sheet, but the latest quarter showed sharply weaker margins and liquidity, making the stock look fairly valued rather than cheap.
Price Behavior
Key Price Behavior Insights:
- •Mid-range consolidation
- •Fading rebound
- •Defined support/resistance
ICLR's short-term trend is mixed, with a sharp rebound from late-April weakness now fading into mid-range consolidation near support, while a move above $121.94-$125 would be needed to reassert upside momentum.
Sharp rebound from late-April weakness, then a pullback from the
Sentiment & News
Key News Insights:
- •Audit delay
- •Stock weakness
- •U.S. expansion
ICON plc is navigating audit-related reporting delays and persistent share कमजोरी even as it expands U.S. early-phase research capacity and continues reshaping its portfolio through asset sales.
The news is mixed but slightly negative overall, with governance uncertainty and market pressure offset only partly by operational investment and portfolio optimization
Similar Companies in Healthcare
Other companies in the same sector with AI ratings